Back to
JPMORGAN CHASE & CO
BOLT5 quarters
Position history for
JPMORGAN CHASE & CO's holdings in BOLT BIOTHERAPEUTICS INC
Yes. JPMorgan Chase holds 42 shares of BOLT (Bolt Biotherapeutics), worth $165, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. JPMorgan Chase has held BOLT since Q2 2025, across 5 quarterly 13F filings.
Current Value
$165
Current Shares
42
Total Value Change
-$86
Total Shares Change
-1
Quarter-by-Quarter History
Other major holders of BOLT: RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, CITADEL ADVISORS LLC